Meetings of the Minds2007

American College of Clinical Pharmacy (ACCP) 2007 Annual Meeting

  • DAY: to be released
  • Place：Denver, Colorado, U.S.A.
  • Evaluations of the Human COX-1 and COX-2 Inhibition for Amfenac, Bromfenac, Diclofenac and Ketorolac.
  • Tetsuo Kida1, Takahiro Ogawa2, Timothy R. McNamara3, Clara K. Song3, James A.Gow3.
    1Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Senju USA, Inc., Woodland Hills, CA; 3Medical Affairs, ISTA Pharmaceuticals, Inc., Irvine, CA.

The Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting

  • DAY: to be released
  • Place：Fort Lauderdale, Florida, U.S.A. : May 6-10, 2007
  • ①Preclinical Pharmacokinetics of Difluprednate Emulsion
    ②Efficacy of Difluprednate Ophthalmic Emulsion in Preclinical Studies of Uveitis
    ③Preclinical Toxicity of Difluprednate Emulsion
    ④Ocular Distribution and Metabolism After Instillation of Difluprednate Ophthalmic Emulsion in Rabbits
    ⑤Difluprednate Emulsion Inhibits Postoperative Inflammation in Rabbit Paracentesis Model
    ⑥Ecabet Sodium Promotes MUC5AC Secretion in Rabbit Tears
    ⑦Species Difference in Corneal Metabolism of Fluorometholone
    ⑧Polylactic Acid for Visualizing Vitreous Body During Vitrectomy
    ⑨Involvement of Cycloxygenase-1 and -2 in Ocular Inflammation and Pain Using a Rabbit Model
    ⑩Long-term Observation of Cultivated Corneal Endothelial Transplantation in Primates
    ⑪Expression of Cell Cycle Molecules in Primate Corneal Endothelial Cells and Primate Cultivated Corneal Endothelial Cells
    ⑫Detection of Mutations in Quinolone Resistance-Determining Regions in Methicillin-Susceptible and -Resistant Clinical Isolates of Staphylococcus epidermidis : Effects of the Mutations on Fluoroquinolone MICs
  • ①J.Inoue, M.Yamaguchi, H.Sakaki, T.Kida, T.Tajika, K.Inada, A.Ohtori.
    Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan.
    ②A.Okumura1, M.Tsuzuki2, T.Wada2, T.Kida2, T.Tajika2, H.Sakaki2, A.Ohtori2.
    1Strategic R&D Planning, Senju Pharmaceutical Co Ltd, Osaka, Japan; 2Research Laboratory, Senju Pharmaceutical Co Ltd, Kobe, Japan.
    ③H.Sakaki, S.Nemoto, T.Kida, T.Tajika, A.Ohtori.
    Research Laboratories, Senju Pharmaceutical Co.,Ltd., Kobe, Japan.
    ④T.Tajika, M.Kimura, T.Kida, H.Sakaki, A.Ohtori.
    Research Laboratories, Senju Pharmaceutical Co., Ltd., Kobe, Japan.
    ⑤T.Kida, H.Takahashi, M.Tsuzuki, T.Tajika, H.Sakaki, A.Ohtori.
    Research Laboratories, Senju Pharmaceutical Co., Ltd., Kobe, Japan.
    ⑥C.Mito1, H.Tokushige1, T.Kida1, H.Sakaki1, T.Ogawa2.
    1Senju Pharmaceutical Co., Ltd., Kobe, Japan; 2Senju USA Inc., Encino, CA.
    ⑦Y.Shirasaki1A, T.Tajika1A, H.Takahashi1B, T.Kida1A, H.Sakaki1A.
    A Laboratory for Preclinical Research; B Drug Discovery Research Laboratory; 1 Senju Pharmaceutical Co., Ltd., Kobe, Japan.
    ⑧T.Sakamoto1, T.Yamashita1, K.Yamakiri1, M.Miura2, H.Enaida2, T.Ishibashi2, I.Atsumi3, K.Matsuhisa3, Y.Sakamoto3, T.Kida3.
    1Ophthalmology, Kagoshima University School of Medicine, Kagoshima, Japan; 2Ophthalmology, Kyushu University, Fukuoka, Japan; 3Senju Pharmaceutical Co. Ltd., Kobe, Japan.
    ⑨T.Ogawa1, T.Kida1, C.K. Song2, J.A. Gow2, T.R. McNamara2.
    1Research and Development, Senju USA, Inc., Encino, CA; 2Medical Affairs, ISTA Pharmaceuticals, Inc., Irvine, CA.
    ⑩N. Koizumi1,4, Y. Sakamoto2, N. Okahara3, H. Tsuchiya3, H. R. Torii3, Cooper LJ4, S. Kinoshita4.
    1Research Center for Regenerative Medicine, Doshisha University; 2Drug Discovery Research Laboratory, Senju Pharmaceutical Co., Ltd.; 3Research Center for Animal Life Science, Shiga University of Medical Science; 4Ophthalmology, Kyoto Prefectural University of Medicine.
    ⑪Naoki Okumura1, Noriko Koizumi1,2, Akira Matsuda1, Yuji Sakamoto3, Shigeru Kinoshita1.
    1Ophthalmology, Kyoto Prefectural University of Medicine; 2Research Center for Regenerative Medicine, Doshisha University; 3Drug Discovery Research Laboratory, Senju Pharmaceutical Co., Ltd.
    ⑫Y. Minagawa1, S. Hatou2, M. Yamada2.
    1Senju Pharmaceutical Co. Ltd.; 2National Institute of Sensory Organs, National Tokyo Medical Center.

American Society of Cataract and Refractive Surgery (ASCRS) 2007 Symposium

  • DAY: to be released
  • Place：San Diego, California, U.S.A.
  • Evaluations of the Human COX-2 Inhibition for Amfenac, Bromfenac, Diclofenac and Ketorolac.
  • Tetsuo Kida1, Takahiro Ogawa2, Timothy R. McNamara3, Clara K. Song3, James A.Gow3.
    1Research Laboratories, Senju Pharmaceutical Co Ltd, Kobe, Japan; 2Senju USA, Inc., Encino, CA; 3Medical Affairs, ISTA Pharmaceuticals, Inc., Irvine, CA.

new | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999